![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 40, 38813-38820, October 3, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








||
**
From the
Department of Medicine, The University of Chicago, Chicago, Illinois 60637, the
Department of Chemistry, University of Illinois, Chicago, Illinois 60607, and the ¶Department of Medicine, Harvard Medical School, Massachusetts General Hospital East, Charlestown, Massachusetts 02129
We previously reported that exogenously added human group V phospholipase A2 (hVPLA2) could elicit leukotriene B4 biosynthesis in human neutrophils through the activation of group IVA phospholipase A2 (cPLA2) (Kim, Y. J., Kim, K. P., Han, S. K., Munoz, N. M., Zhu, X., Sano, H., Leff, A. R., and Cho, W. (2002) J. Biol. Chem. 277, 36479-36488). In this study, we determined the functional significance and mechanism of the exogenous hVPLA2-induced arachidonic acid (AA) release and leukotriene C4 (LTC4) synthesis in isolated human peripheral blood eosinophils. As low a concentration as 10 nM exogenous hVPLA2 was able to elicit the significant release of AA and LTC4 from unstimulated eosinophils, which depended on its ability to act on phosphatidylcholine membranes. hVPLA2 also augmented the release of AA and LTC4 from eosinophils activated with formyl-Met-Leu-Phe + cytochalasin B. A cellular fluorescent PLA2 assay showed that hVPLA2 had a lipolytic action first on the outer plasma membrane and then on the perinuclear region. hVPLA2 also caused the translocation of 5-lipoxygenase from the cytosol to the nuclear membrane and a 2-fold increase in 5-lipoxygenase activity. However, hVPLA2 induced neither the increase in intracellular calcium concentration nor cPLA2 phosphorylation; consequently, cPLA2 activity was not affected by hVPLA2. Pharmacological inhibition of cPLA2 and the hVPLA2-induced activation of eosinophils derived from the cPLA2-deficient mouse corroborated that hVPLA2 mediates the release of AA and leukotriene in a cPLA2-independent manner. As such, this study represents a unique example in which a secretory phospholipase induces the eicosanoid formation in inflammatory cells, completely independent of cPLA2 activation.
Received for publication, March 11, 2003 , and in revised form, June 5, 2003.
* This work was supported by National Institutes of Health Grants GM52598 (to W. C.), HL-46368 (to A. R. L.), Specialized Center of Research Grant HL-56399 (to A. R. L.), and a Center of Excellence grant from GlaxoSmithKline, UK (to A. R. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence may be addressed: Section of Pulmonary and Critical Care Medicine, Dept. of Medicine, MC6076, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637. Tel.: 773-702-1859; Fax: 773-702-9181; E-mail: aleff{at}medicine.bsd.uchicago.edu.
** To whom correspondence may be addressed: Dept. of Chemistry (M/C 111), University of Illinois at Chicago, 845 West Taylor St., Chicago, IL 60607-7061. Tel.: 312-996-4883; Fax: 312-996-2183; E-mail: wcho{at}uic.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
B. P. Hurley and B. A. McCormick Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation Infect. Immun., June 1, 2008; 76(6): 2259 - 2272. [Full Text] [PDF] |
||||
![]() |
A. R. Leff and N. M. Munoz Future Treatment to Lessen Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2007; 4(8): 659 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hallstrand, E. Y. Chi, A. G. Singer, M. H. Gelb, and W. R. Henderson Jr. Secreted Phospholipase A2 Group X Overexpression in Asthma and Bronchial Hyperresponsiveness Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1072 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Munoz, A. Y. Meliton, J. P. Arm, J. V. Bonventre, W. Cho, and A. R. Leff Deletion of Secretory Group V Phospholipase A2 Attenuates Cell Migration and Airway Hyperresponsiveness in Immunosensitized Mice J. Immunol., October 1, 2007; 179(7): 4800 - 4807. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kikawada, J. V. Bonventre, and J. P. Arm Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2{alpha} activation Blood, July 15, 2007; 110(2): 561 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuwata, C. Fujimoto, E. Yoda, S. Shimbara, Y. Nakatani, S. Hara, M. Murakami, and I. Kudo A Novel Role of Group VIB Calcium-independent Phospholipase A2 (iPLA2{gamma}) in the Inducible Expression of Group IIA Secretory PLA2 in Rat Fibroblastic Cells J. Biol. Chem., July 13, 2007; 282(28): 20124 - 20132. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ruiperez, J. Casas, M. A. Balboa, and J. Balsinde Group V Phospholipase A2-Derived Lysophosphatidylcholine Mediates Cyclooxygenase-2 Induction in Lipopolysaccharide-Stimulated Macrophages J. Immunol., July 1, 2007; 179(1): 631 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohtsuki, Y. Taketomi, S. Arata, S. Masuda, Y. Ishikawa, T. Ishii, Y. Takanezawa, J. Aoki, H. Arai, K. Yamamoto, et al. Transgenic Expression of Group V, but Not Group X, Secreted Phospholipase A2 in Mice Leads to Neonatal Lethality because of Lung Dysfunction J. Biol. Chem., November 24, 2006; 281(47): 36420 - 36433. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Munoz, A. Y. Meliton, A. Lambertino, E. Boetticher, J. Learoyd, F. Sultan, X. Zhu, W. Cho, and A. R. Leff Transcellular Secretion of Group V Phospholipase A2 from Epithelium Induces beta2-Integrin-Mediated Adhesion and Synthesis of Leukotriene C4 in Eosinophils J. Immunol., July 1, 2006; 177(1): 574 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ni, N. M. Okeley, B. P. Smart, and M. H. Gelb Intracellular Actions of Group IIA Secreted Phospholipase A2 and Group IVA Cytosolic Phospholipase A2 Contribute to Arachidonic Acid Release and Prostaglandin Production in Rat Gastric Mucosal Cells and Transfected Human Embryonic Kidney Cells J. Biol. Chem., June 16, 2006; 281(24): 16245 - 16255. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Wijewickrama, J.-H. Kim, Y. J. Kim, A. Abraham, Y. Oh, B. Ananthanarayanan, M. Kwatia, S. J. Ackerman, and W. Cho Systematic Evaluation of Transcellular Activities of Secretory Phospholipases A2: HIGH ACTIVITY OF GROUP V PHOSPHOLIPASES A2 TO INDUCE EICOSANOID BIOSYNTHESIS IN NEIGHBORING INFLAMMATORY CELLS J. Biol. Chem., April 21, 2006; 281(16): 10935 - 10944. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Balestrieri, V. W. Hsu, H. Gilbert, C. C. Leslie, W. K. Han, J. V. Bonventre, and J. P. Arm Group V Secretory Phospholipase A2 Translocates to the Phagosome after Zymosan Stimulation of Mouse Peritoneal Macrophages and Regulates Phagocytosis J. Biol. Chem., March 10, 2006; 281(10): 6691 - 6698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Shoseyov, H Bibi, S Offer, O Schwob, M Krimsky, M Kleiman, and S Yedgar Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A2 Thorax, September 1, 2005; 60(9): 747 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuwata, T. Nonaka, M. Murakami, and I. Kudo Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway J. Biol. Chem., July 8, 2005; 280(27): 25830 - 25839. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, S. Masuda, S. Shimbara, Y. Ishikawa, T. Ishii, and I. Kudo Cellular Distribution, Post-translational Modification, and Tumorigenic Potential of Human Group III Secreted Phospholipase A2 J. Biol. Chem., July 1, 2005; 280(26): 24987 - 24998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuda, M. Murakami, Y. Takanezawa, J. Aoki, H. Arai, Y. Ishikawa, T. Ishii, M. Arioka, and I. Kudo Neuronal Expression and Neuritogenic Action of Group X Secreted Phospholipase A2 J. Biol. Chem., June 17, 2005; 280(24): 23203 - 23214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Offer, S. Yedgar, O. Schwob, M. Krimsky, H. Bibi, A. Eliraz, Z. Madar, and D. Shoseyov Negative feedback between secretory and cytosolic phospholipase A2 and their opposing roles in ovalbumin-induced bronchoconstriction in rats Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L523 - L529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luo, S. M. Jones, S. M. Phare, M. J. Coffey, M. Peters-Golden, and T. G. Brock Protein Kinase A Inhibits Leukotriene Synthesis by Phosphorylation of 5-Lipoxygenase on Serine 523 J. Biol. Chem., October 1, 2004; 279(40): 41512 - 41520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Satake, B. L. Diaz, B. Balestrieri, B. K. Lam, Y. Kanaoka, M. J. Grusby, and J. P. Arm Role of Group V Phospholipase A2 in Zymosan-induced Eicosanoid Generation and Vascular Permeability Revealed by Targeted Gene Disruption J. Biol. Chem., April 16, 2004; 279(16): 16488 - 16494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Balboa, Y. Shirai, G. Gaietta, M. H. Ellisman, J. Balsinde, and E. A. Dennis Localization of Group V Phospholipase A2 in Caveolin-enriched Granules in Activated P388D1 Macrophage-like Cells J. Biol. Chem., November 28, 2003; 278(48): 48059 - 48065. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |